Artículos originales \ Editorial
Are we ripe for preventive percutaneous coronary interventions?
aDepartment of Cardiology, McGill University Health Center, Montreal, Quebec, Canada
bDepartment of Structural Heart Disease, Silesian Medical University, Katowice, Poland
DOI: https://doi.org/10.24875/RECICE.M24000480
Disponible online: 24/09/2024
Percutaneous coronary intervention of the left main in the elderly: a reasonable option
Department of Cardiology and Angiology, University Heart Center Freiburg · Bad Krozingen, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
DOI: https://doi.org/10.24875/RECICE.M24000474
Disponible online: 14/08/2024
The challenging pathway to TAVI: in memory of Alain Cribier
aServicio de Cardiología Intervencionista, Hospital Gregorio Marañón, Hospital Clínico San Carlos, Hospital Montepríncipe y Hospital Moncloa, Madrid, Spain
bServicio de Cardiología Intervencionista, Hospital Montepríncipe y Hospital Moncloa, Madrid, Spain
REC Interv Cardiol. 2024;6:151-152
Clinical evaluation requirements under the new European Union medical device regulation
Centro Nacional de Certificación de Productos Sanitarios, Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), Madrid, Spain
DOI: https://doi.org/10.24875/RECICE.M24000449
Disponible online: 20/05/2024
Misconceptions and misunderstandings hampering medical research and progress
aCátedra Internacional de Análisis Estadístico y Big Data, Facultad de Medicina, UCAM Universidad Católica de Murcia, Guadalupe de Maciascoque, Murcia, Spain
bADA.RT Advanced Data Analysis Research and Teaching, Madrid, Spain
cServicio de Cardiología, Hospital General Universitario Gregorio Marañón, Madrid, Spain
dCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain
eFacultad de Ciencias Biomédicas y de la Salud, Universidad Europea de Madrid, Villaviciosa de Odón, Madrid, Spain
fFacultad de Medicina, Universidad Complutense, Madrid, Spain
REC Interv Cardiol. 2024;6:156-157
Ventricular pressure-volume loop and other heart function metrics can elucidate etiology of failure of TAVI and interventions
aDepartment of Mechanical Engineering, McMaster University, Hamilton, Ontario, Canada
bSchool of Biomedical Engineering, McMaster University, Hamilton, Ontario, Canada
REC Interv Cardiol. 2024;6:153-155
Drug-coated balloons on the “big stage”: is this technology ready for an all-comer population with de novo lesions?
aDepartment of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland
bDCB Academy, Milano, Italy
c1st Department of Cardiology, Poznan University of Medical Sciences, Poznań, Poland
dCardiovascular Research Center, Fondazione Ricerca e Innovazione Cardiovascolare, Milano, Italy
DOI: https://doi.org/10.24875/RECICE.M23000437
Disponible online: 05/02/2024
Implementing an ANOCA clinic
aCardiovascular Center Aalst, OLV Clinic, Aalst, Belgium
bDepartment of Cardiology, Lausanne University Hospital, Lausanne, Switzerland
REC Interv Cardiol. 2024;6:61-62
Percutaneous pulmonary valve implantation in native outflow tracts: has the time come?
Servicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain
REC Interv Cardiol. 2024;6:63-66
Transcatheter aortic valve replacement for noncalcified aortic regurgitation. Where are we now?
aServicio de Cardiología, Hospital Clínico Universitario, Valladolid, Spain
bCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain
REC Interv Cardiol. 2024;6:3-6
Page 1 of 6